Navigation Links
Cantox Announces the Launch of Ashuren Health Sciences Pharmaceutical Division
Date:1/10/2008

MISSISSAUGA, Ontario, BRIDGEWATER, New Jersey and BIRMINGHAM, Alabama, Jan. 10 /PRNewswire/ -- CANTOX HEALTH SCIENCES INC. and CANTOX US INC., a leading international scientific and regulatory consulting firm with specialized expertise in the areas of Pharmaceutical & Healthcare, Food & Nutrition, Chemicals and Agriculture, Biotech & Consumer Products announces the launch of Ashuren Health Sciences as the new name for their Pharmaceutical & Healthcare Division.

For the past 20 years, Cantox has been helping clients resolve complex scientific and toxicology issues, develop scientific and strategic regulatory plans, and facilitating timely regulatory global approvals. Cantox has been optimizing success and minimizing client risk through broad expertise and knowledge.

"The decision to rename the Pharmaceutical & Healthcare Division 'ASHUREN Health Sciences' was taken in order to more accurately represent our expanding global client base and to reflect our diverse international regulatory agency interactions," said Lindsay N. Donald, Vice President of Ashuren Pharmaceutical & Healthcare. "We have been assisting clients with their toxicology and drug development issues in Europe, North America, Asia and Australia."

"In order to rapidly and cost effectively move drugs through development it is imperative to anticipate scientific and regulatory issues ahead of time," commented Anna Metcalfe, Vice President of Regulatory Affairs for Ashuren. "This is where the experience of Ashuren's scientific and regulatory affairs consultants can really aid our pharmaceutical and biotech clients."

About Ashuren

Ashuren Health Sciences is a focused team of scientific and regulatory consultants that can help develop strategies, provide expert advice on all aspects of product development programs, and provide advice on a wide variety of toxicology and regulatory issues for pharmaceutical and related products. With diverse and in-depth experience in pharmaceutical development, our resourceful and innovative team consisting of board-certified toxicologists, regulatory affairs specialists and scientific writers address client's needs and accelerate their development programs. For more information, please visit: http://www.ashuren.com.


'/>"/>
SOURCE Ashuren Health Sciences
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
Breaking Biology Technology:
(Date:6/9/2016)... leader in attendance control systems is proud to announce the introduction of fingerprint attendance ... the right employees are actually signing in, and to even control the opening of ... ... ... Photo - ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:6/2/2016)... -- Perimeter Surveillance & Detection Systems, Biometrics ... Support & Other Service  The latest report ... analysis of the global Border Security market . ... $17.98 billion in 2016. Now: In November ... software and hardware technologies for advanced video surveillance. ...
Breaking Biology News(10 mins):